| Identification | |
| Name: | dihydro- |
| Synonyms: | Vitamin K hydroquinone;Phytonadiol;Vitamin K1 hydroquinone;3-methyl-2-[(7R,11R)-3,7,11,15-tetramethylhexadec-2-enyl]naphthalene-1,4-diol;2-methyl-3-[(2E,7R,11R)-3,7,11,15-tetramethylhexadec-2-en-1-yl]naphthalene-1,4-diol;(R-(R*,R*-(E)))-2-Methyl-3-(3,7,11,15-tetramethylhexadec-2-enyl)naphthalene-1,4-diol;1,4-Naphthalenediol,2-methyl-3-[(2E,7R,- 11R)-3,7,11,15-tetramethyl-2-hexadecenyl]-;3-methyl-2-[(E,7R,11R)-3,7,11,15-tetramethylhexadec-2-enyl]naphthalene-1,4-diol; |
| CAS: | 572-96-3 |
| EINECS: | 209-344-8 |
| Molecular Formula: | C31H48O2 |
| Molecular Weight: | 452.71 |
| InChI: | InChI=1/C31H48O2/c1-22(2)12-9-13-23(3)14-10-15-24(4)16-11-17-25(5)20-21-27-26(6)30(32)28-18-7-8-19-29(28)31(27)33/h7-8,18-20,22-24,32-33H,9-17,21H2,1-6H3/b25-20+ |
| Molecular Structure: |  |
| Properties | |
| Density: | 0.981 |
| Refractive index: | 1.543 |
| Specification: |
Dihydrovitamin K1 belongs to the categories of Various Metabolites and Impurities; Inhibitors; Intermediates & Fine Chemicals; Metabolites & Impurities; Pharmaceuticals. Specifically, this compound is the metabolite of vitamin K1 & vitamin K1 2,3-epoxide . Its IUPAC name is called 2-methyl-3-[(E,7R,11R)-3,7,11,15-tetramethylhexadec-2-enyl]naphthalene-1,4-diol . And the systematic name is named 2-methyl-3-[(2E,7R,11R)-3,7,11,15-tetramethylhexadec-2-en-1-yl]naphthalene-1,4-diol . The SMILES is short ASCII strings for describing the structure which is Oc2c1ccccc1c(O)c(c2C)C\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C. The Dihydrovitamin K1 has several physical properties including: (1)H bond acceptors: 2; (2)H bond donors: 2; (3)Freely Rotating Bonds: 16; (4)Index of Refraction: 1.543; (5)Molar Refractivity: 145.4 cm3; (6)Molar Volume: 461.1 cm3; (7)Surface Tension: 38.2 dyne/cm; (8)Enthalpy of Vaporization: 91.17 kJ/mol; (9)Vapour Pressure: 1.79E-14 mmHg at 25°C |
| Usage: | A metabolite of Vitamin K1 |
| Safety Data | |
 |
|
